HEALTH Secretary Francisco Duque III announced that the interval for the administration of booster doses shall be shortened, following the approval of the Food and Drug Administration (FDA). The shortened interval shall be effective on 22 December 2021.
Under this new policy, boosters may already be given to adults at least three months after the second dose of a primary two-dose vaccine, or least two months after the primary single-dose vaccine is given.
“We are exploring all possible options to safely mitigate the effects of more transmissible variants of COVID-19. The approval came at an opportune time as several countries also re-strategized in light of the Omicron and other COVID-19 variants that may emerge,” said Duque.
Further, the DOH reiterates the importance of prioritizing vaccination among those who are yet to receive their primary series.
“We call on our local government units to encourage their constituents to get vaccinated, especially the unvaccinated senior citizens and people with underlying medical conditions who are more vulnerable to having severe COVID-19. Ensuring enough coverage of the primary series while adhering to the minimum public health standards are crucial if we want to maintain low to minimal risk classification and have adequate health systems capacities especially during the holiday season,” Duque added.
